Skip to main content

Table 4 Correlation between plasma IgG and HbA1c levels in T2D patients before and after glucose-lowering treatment

From: Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance

Antigen Before treatment 3-month treatment 6-month treatment
r p a r p b r p c
IL1α -0.024 0.762 -0.005 0.978 -0.477 0.039
IL1β -0.011 0.888 -0.030 0.875 -0.278 0.250
IL6 -0.052 0.517 -0.191 0.304 -0.519 0.023
IL8 -0.089 0.266 -0.239 0.196 -0.400 0.090
TNF-α 0.069 0.384 -0.129 0.489 -0.137 0.576
  1. adf=157; bdf=29; cdf=17